Skip to main content

Table 3 Results of cost-utility analysis

From: An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany

 

Cost, €

∆ cost €

Life years gained

∆ LYG

QALYs gained

∆ QALY

ICER, €/QALY

BAT

50,856 [34,358-59,437]

33,185 [24,561-38,637]

7.25 [3.44–9.17]

1.78 [0.45–2.71]

4.86 [2.30–6.14]

1.19 [0.30–1.81]

27,951 [21,357-82,970]

OMM

17,671 [9796-20,800]

5.47 [3.00–6.46]

3.67 [2.00–4.33]